Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shigeyuki Motegi is active.

Publication


Featured researches published by Shigeyuki Motegi.


Hepatitis Research and Treatment | 2010

Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral Titer Chronic Hepatitis C

Makoto Numata; Tatehiro Kagawa; Seiichiro Kojima; Shunji Hirose; Naruhiko Nagata; Koichi Shiraishi; Norihito Watanabe; Hirokazu Shiozawa; Yasuhiro Nishizaki; Shigeyuki Motegi; Shinji Takashimizu; Junichiro Kamochi; Mitsuru Wasada; Takashi Ohno; Yoshihiro Tei; Atsushi Nakano; Takuji Yamada; Kazuhiro Atsukawa; Tetsu Watanabe; Tetsuya Mine

To clarify the impact of adherence, we treated 122 genotype 1 high viral titer chronic hepatitis C patients with pegylated interferon (peg-IFN) and ribavirin for 48 weeks at nine referral hospitals, and evaluated the prognostic factors with a focus on the adherence to the treatment. This study included 68 (55.7%) treatment-naïve patients and 54 (44.3%) patients who did not respond to the previous treatment. Multivariate analysis revealed adherence to peg-IFN and ribavirin as the only significant predictor. Sustained virological response (SVR) rate was 72.2%, 19.0%, and 27.3% in patients given ≥80%, 60%–80%, and <60% dose peg-IFN, respectively, and was 68.6%, 41.2%, and 5.3% in those given ≥80%, 60%–80%, and <60% dose ribavirin, respectively. SVR rate sharply fell when exposure to peg-IFN was below 80% whereas it decreased in a stepwise manner as for ribavirin. Therefore, ≥80% of peg-IFN and as much as possible dose of ribavirin are desired to achieve SVR in the treatment of genotype 1 high viral titer chronic hepatitis C.


Alcoholism: Clinical and Experimental Research | 2003

Influence of Acute Alcohol Load on Metabolism of Skeletal Muscles—Expired Gas Analysis During Exercise

Koichi Shiraishi; Mitsuyuki Watanabe; Shigeyuki Motegi; Reiko Nagaoka; Shohei Matsuzaki; Hiroki Ikemoto

BACKGROUND The chronic intake of alcohol affects the function of skeletal muscles. To elucidate the influence of acute alcoholic load on muscular metabolism during exercise, we analyzed expired gases to measure the volume of consumed oxygen and the volume of exhaled CO2. METHODS Healthy volunteers were enrolled for the study. For the exercise test, they were asked to rest for 5 min, warm up on an aerobike at 20 W for 2 min, and then gradually increase the load by 2 W every 6 sec. On another day, they were asked to drink 0.5 to 0.6 g/kg ethanol in 30 min, rest for 30 min, and then do the test. The expired gas analysis was used to measure changes in the anaerobic threshold and the respiratory compensation point. The blood concentrations of lactate, ethanol, and acetate also were measured. RESULTS The anaerobic threshold showed no significant change in the case of exercise without alcoholic load. The respiratory compensation point decreased significantly in the case of alcoholic load (p < 0.001), and the interval from the anaerobic threshold to the respiratory compensation point decreased (p < 0.02). The blood concentration of lactate increased, after alcoholic load, to a level significantly higher than the level measured before the alcoholic load (p < 0.001). It showed a marked increase immediately after exercise stress (p < 0.001). The blood concentration of acetate tended to decrease after exercise load, but no significant change was noted. CONCLUSIONS The anaerobic threshold, which is the limit of the aerobic glycolytic system (i.e., the so-called aerobic exercise limit) was not influenced by exercise under an acute alcoholic load. However, after the production of lactate started, the respiratory compensation point, which is the limit of the metabolic compensatory action, appeared earlier. This suggested that the intake of alcohol would influence the energy metabolism of skeletal muscles by a mechanism in which the disturbed metabolism of lactate in skeletal muscles was mainly involved.


Journal of Gastroenterology | 2003

Hemophagocytic syndrome in ileum-origin B-cell lymphoma

Shigeyuki Motegi; Yasuhiro Nishizaki; Chikashi Muramatsu; Hiroyuki Nakamura; Fuminori Kobayashi; Hirokazu Shiozawa; Junichiro Kamochi; Masaru Itakura; Makoto Shibuya; Tetsuhei Ogawa; Shohei Matsuzaki

A 56 year-old-man was admitted due to upper abdominal tumor and was diagnosed as having stage IVb diffuse B-cell malignant lymphoma that originally developed in the terminal ileum. The first and the second administrations of CHOP (cyclophosphamide, 750 mg/m2; adriamycin, 50 mg/m2; vincristine, 1.4 mg/m2; and prednisolone, 100 mg/day) therapy were effective; however, the third course of therapy was postponed because of an episode of massive hematochezia. After this episode, lymph nodes began to enlarge and progressive pancytopenia occurred. Bone marrow smear showed the proliferation of reactive histiocytic cells which phagocytized red blood cells, white blood cells, and platelets. B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS) was diagnosed. This case is extremely rare because: (1) LAHS occurred in an ileum-origin B-cell lymphoma, and (2) LAHS developed during an interval after chemotherapy.


総合健診 | 2012

Anti-aging health check-up system:— For the prevention of potentially progress aging related disadvantageous changes in elderly —

Yasuhiro Nishizaki; Akira Kubo; Ichiro Kuwahira; Emiko Kuroda; Noriko Nigou; Toshiharu Sueno; Shigeyuki Motegi; Hirokazu Shiozawa; Norihito Watanabe; Tetsuhei Ogawa; Ryuzaburo Tanino; Naoaki Ishii


Health Evaluation and Promotion | 2012

Anti-aging health check-up system

Yasuhiro Nishizaki; Akira Kubo; Ichiro Kuwahira; Emiko Kuroda; Noriko Nigou; Toshiharu Sueno; Shigeyuki Motegi; Hirokazu Shiozawa; Norihito Watanabe; Tetsuhei Ogawa; Ryuzaburo Tanino; Naoaki Ishii


Health Evaluation and Promotion | 2016

Serum ferritin and high sensitivity C-reactive protein are associated with metabolic syndrome in Japanese men and women

Chizumi Yamada; Noriaki Kishimoto; Nobushige Yukumatsu; Asami Takeda; Tamae Ogata; Emiko Kikuchi; Emiko Kuroda; Shigeyuki Motegi; Naoaki Ishii; Yasuhiro Nishizaki


Alcoholism: Clinical and Experimental Research | 2005

Study of energy metabolism of skeletal muscles in alcoholic liver disease--expired gas analysis during exercise.

Koichi Shiraishi; Shigeyuki Motegi; Reiko Nagaoka; Fusao Ogasawara; Tetsuro Saito; Mitsuyuki Watanabe; Shohei Matsuzaki


総合健診 | 2013

An approach to providing supplement advice in health evaluation and promotion:— Including experiences from our anti-aging health check-up system —

Chizumi Yamada; Masumi Kondo; Masahiro Kikuchi; Masashi Matsushima; Shigeyuki Motegi; Akira Kubo; Naoaki Ishii; Yasuhiro Nishizaki


Japanese journal of geriatrics | 2013

[Seven years' results of anti-aging health check-up system in Tokai University Tokyo Hospital--from establishment to present and the future].

Yasuhiro Nishizaki; Chizumi Yamada; Shigeyuki Motegi; Emiko Kuroda; Ichiro Kuwahira; Ryuzaburo Tanino; Akira Kubo; Naoaki Ishii


Health Evaluation and Promotion | 2013

An approach to providing supplement advice in health evaluation and promotion

Chizumi Yamada; Masumi Kondo; Masahiro Kikuchi; Masashi Matsushima; Shigeyuki Motegi; Akira Kubo; Naoaki Ishii; Yasuhiro Nishizaki

Collaboration


Dive into the Shigeyuki Motegi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akira Kubo

International University of Health and Welfare

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shohei Matsuzaki

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge